1987Headache The Journal of Head and Face PainRequires access

Nimodipine versus Flunarizine in Common Migraine: A Controlled Pilot Trial

Gennaro Bussone, S. Baldini, G D’Andrea, A.R. Cananzi, Fabio Frediani, L. Caresia, Francesco Milone, A. Boiardi

Open publisher page 25 citations

Abstract

SYNOPSIS The effects of Nimodipine and Flunarizine, both calcium‐antagonist drugs, in the prevention of common migraine were investigated in a double‐blind randomized parallel study. Five patients of the 30 included in the study dropped out because of adverse reactions. Two were treated with Nimodipine and three with Flunarizine. Our results suggest a similar efficacy for both drugs, although Nimodipine seems to have a shorter latency of effect. Nimodipine is a useful new agent for common migraine prevention.

About this research paper

What this paper is about

SYNOPSIS The effects of Nimodipine and Flunarizine, both calcium‐antagonist drugs, in the prevention of common migraine were investigated in a double‐blind randomized parallel study. Five patients of the 30 included in the study dropped out because of adverse reactions. Two were treated with Nimodipine and three with Flunarizine. Our results suggest a similar efficacy for both drugs, although Nimodipine seems to have a shorter latency of effect. Nimodipine is a useful new agent for common migraine prevention.

Why it matters

OpenAlex reports 25 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

SYNOPSIS The effects of Nimodipine and Flunarizine, both calcium‐antagonist drugs, in the prevention of common migraine were investigated in a double‐blind randomized parallel study. Five patients of the 30 included in the study dropped out because of adverse reactions. Two were treated with Nimodipine and three with Flunarizine. Our results suggest a similar efficacy for both drugs, although Nimodipine seems to have a shorter latency of effect. Nimodipine is a useful new agent for common migraine prevention.

Key concepts: Flunarizine, Nimodipine, Medicine, Migraine, Anesthesia, Antagonist, Randomized controlled trial, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Nimodipine versus Flunarizine in Common Migraine: A Controlled Pilot Trial — Research Paper | ScholarLens